These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Hypovascular hypointense nodules on hepatobiliary phase gadoxetic acid-enhanced MR images in patients with cirrhosis: potential of DW imaging in predicting progression to hypervascular HCC. Kim YK, Lee WJ, Park MJ, Kim SH, Rhim H, Choi D. Radiology; 2012 Oct; 265(1):104-14. PubMed ID: 22891358 [Abstract] [Full Text] [Related]
25. Comparison of portal venous and delayed phases of gadolinium-enhanced magnetic resonance imaging study of cirrhotic liver for the detection of contrast washout of hypervascular hepatocellular carcinoma. Cereser L, Furlan A, Bagatto D, Girometti R, Como G, Avellini C, Orsaria M, Zuiani C, Bazzocchi M. J Comput Assist Tomogr; 2010 Oct; 34(5):706-11. PubMed ID: 20861773 [Abstract] [Full Text] [Related]
30. Hepatic hemangiomas: difference in enhancement pattern on 3T MR imaging with gadobenate dimeglumine versus gadoxetate disodium. Gupta RT, Marin D, Boll DT, Husarik DB, Davis DE, Feuerlein S, Merkle EM. Eur J Radiol; 2012 Oct; 81(10):2457-62. PubMed ID: 22138122 [Abstract] [Full Text] [Related]
31. [Evaluation of noninvasive diagnostic criteria for hepatocellular carcinoma on pretransplant MRI (2010): correlation between MR imaging features and histological features on liver specimen]. Ouedraogo W, Tran-Van Nhieu J, Baranes L, Lin SJ, Decaens T, Laurent A, Djabbari M, Pigneur F, Duvoux C, Kobeiter H, Deux JF, Rahmouni A, Luciani A. J Radiol; 2011 Oct; 92(7-8):688-700. PubMed ID: 21819911 [Abstract] [Full Text] [Related]
32. Hepatic malignancies: usefulness of acquisition of multiple arterial and portal venous phase images at dynamic gadolinium-enhanced MR imaging. Peterson MS, Baron RL, Murakami T. Radiology; 1996 Nov; 201(2):337-45. PubMed ID: 8888220 [Abstract] [Full Text] [Related]
36. Enhancement of the liver and pancreas in the hepatic arterial dominant phase: comparison of hepatocyte-specific MRI contrast agents, gadoxetic acid and gadobenate dimeglumine, on 3 and 1.5 Tesla MRI in the same patient. Kim HJ, Kim BS, Kim MJ, Kim SH, de Campos RO, Hernandes M, Semelka RC. J Magn Reson Imaging; 2013 Apr; 37(4):903-8. PubMed ID: 23065959 [Abstract] [Full Text] [Related]
38. Hepatocellular carcinoma: imaging patterns on gadoxetic acid-enhanced MR Images and their value as an imaging biomarker. Choi JW, Lee JM, Kim SJ, Yoon JH, Baek JH, Han JK, Choi BI. Radiology; 2013 Jun; 267(3):776-86. PubMed ID: 23401584 [Abstract] [Full Text] [Related]